The Latest Drugs and Small Molecule Inhibitors for Skin and Hair

J Drugs Dermatol. 2017 Dec 1;16(12):1224-1228.

Abstract

Biologic drugs, a novel class of agents engineered to target specific mediators of inflammation, and small-molecule inhibitors that penetrate the cell membrane to interact with targets inside a cell represent the cutting-edge of pharmacological biomedical therapeutics. Clinical studies have already demonstrated the effectiveness of this new generation of drugs in treating a variety of medical illnesses and conditions that were refractory to traditional treatments. This review aims to describe the latest available or currently in-development drugs, biologic agents, and small molecule inhibitors for treatment of psoriasis, rosacea, alopecia areata, and atopic dermatitis.

Publication types

  • Review

MeSH terms

  • Alopecia Areata / drug therapy
  • Biological Products / administration & dosage
  • Biological Products / therapeutic use*
  • Dermatitis, Atopic / drug therapy
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / therapeutic use*
  • Drug Approval
  • Humans
  • Psoriasis / drug therapy
  • Rosacea / drug therapy
  • Skin Diseases / drug therapy*

Substances

  • Biological Products
  • Dermatologic Agents